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In previous reports we have described a number of unsaturated, lipoid-soluble
compounds which, after a single local application to the skin of laboratory ani-
mals, caused reversible, conpiete depilation, by temporarily interfering with
hair formation. These substances included the synthetic chioroprene dimers, (1,
2, 3), several allyl esters (4) and ethers (5); and the naturally occurring vitamin
A (3, 4), human sebum and some of the unsaturated components of sebum (3, 6,
7). With the exception of vitamin A, all these substances inactivated sulfhydryl
compounds in vitro. We postulated that the depilatory action of these agents was
related to their sulfhydryl inhibitory activity and that both these effects were
due to the presence of —C==C----- bonds in the molecules which combined with
the free sulfhydryl groups of tissue proteins.
The present report deals with the anti-keratinizing activity of human sebum
and vitamin A. The word "anti-keratinizing" is used to indicate prevention of
hair formation in laboratory animals and reduction of scale formation in man.
The material is presented in three sections: 1. In vivo and in vitro studies with
various types of human sebum and sebum fractions. 2. The role of —C=C—
groups in producing depilation in vivo and sulfhydryl inhibition in vitro. 3. Pre-
liminary clinical data concerning the use of vitamin A, applied topically, in treat-
ment of skin diseases, characterized by excessive or abnormal keratinization.
MATERIAL AND METHODS
1. Studies with different types of human sebum and sebum fractions
Two sources of human "sebum" were used: 1. Hair fat obtained by ether
extraction of human hair, as described previously (3, 6). 2. Human skin lipids,
collected from T-shirts by the Chemical Research Division of Procter and Gamble
and obtained through courtesy of Dr. Raymond R. Suskind.
Hair fat was obtained from the hair of adult males and females and children
of both sexes under the age of puberty. These samples were tested for their suif-
hydryl inhibitory activity in vitro, as described in previous reports (3, 4, 6, 7).
For in vivo depilatory tests only rabbits were used in the present study, as pre-
viously we have found that this species responds in all cases with loss of hair to a
single application of undiluted human sebum.
The human skin lipids collected from T-shirts were fractionated by the Chemi-
cal Research Division of Procter and Gamble. The fractions made available for
our studies are presented in Table I.
* From the Department of Dermatology and Syphilology, School of Medicine, Tjniver-
sity of Pennsylvania (Donald M. Pillsbury, M.D., Professor.) This study was done under
a Damon Runyon Senior Clinical Fellowship of the American Cancer Society, Inc., and
with the assistance of a grant from the Committee on Research, Council on Pharmacy
and Chemistry, American Medical Association.
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Another fraction from human hair fat, containing saturated hydrocarbons,
was obtained through the courtesy of Dr. Rothman.
2. Studies on the essential role of unsaturated groupings for the in vivo depilatory
and in vitro sulfhydryl inactivating action
In order to test the theory that the presence of the —OH=CH----- groups was
essential for the depilatory and sulfhydryl inhibitory effects, several unsaturated
depilatory compounds were hydrogenated. This procedure transforms the un-
saturated bonds to —0112—C112— groupings. The following hydrogenated sub-
stances were tested:
a. Sebum. Twenty grams of sebum, obtained by ether extraction of hair from barber
shops, was found to have an iodine number of 76. This material was divided into two equal
fractions. Both were dissolved in ethyl acetate and Raney nickel catalyst was added to
each. One fraction was hydrogenated at room temperature and 50 psi for 2 days. It absorbed
TABLE I
T-shirt lipids*
FRACTION IODINENUMBER
SAPONIFICATION
NUMBER
1. Total lipids (obtained by ether extraction of T-shirts)....
2. Petroleum ether insoluble fraction of 1
3. "Phospholipid" fraction
4. Water-soluble fraction of petroleum ether extract of 1. ...
5. "Ether" fatty acids (short chain fatty acids)
8. Unsaturated fatty acids
Not given
Not given
10
0
50
69
Not given
Not given
124
155
270
201
* It is beyond the scope of this paper to give a detailed scheme of the fractionation
procedure. The author will be glad to furnish this diagram upon request to interested
readers.
60% of the theoretical volume of hydrogen. The other fraction was shaken with the catalyst
in the absence of hydrogen. The catalyst and solvent were removed from both fractions.
Since the hydrogenated material still absorbed bromine, indicating the presence of unsat-
urated compounds, both samples were again dissolved in ethyl acetate and the above pro-
cedure was repeated. The partially hydrogenated material absorbed no additional hydrogen
over a period of 3 days. The catalyst and solvent were again removed. The partially hy-
drogenated material had an iodine number of 27. From these data it can be seen that in the
case of sebum only partial hydrogenation could be achieved. The partially hydrogenated
sebum and its control, both weighing 10 grams, were used for in vivo and in vitro studies.
b. Squalene. Three types of hydrogenated squalene (dodecahydro-squalene or perhydro-
squalene) were used. The first sample was obtained by high pressure hydrogenation of a
relatively pure preparation of squalene (DuPont). This compound was purified by distilla-
tion (B.P. 195°—205° at 0.3 mm. pressure). It had an index of refraction of 1.4519 at 20° (re-
ported index: 1.4532 at 20°) and showed no evidence of unsaturation when tested with bro-
mine solution. The second sample was prepared in a similar way from a "technical grade"
product of squalene. This material had an index of refraction of 1.4511 at 20°. It had not been
distilled, but was free of solvent and showed no evidence of unsaturation. Finally, a com-
mercial preparation (trade name "Cosbiol") was obtained through courtesy of the French
chemical company, Alimentation Equi1ibre. It had an index of refraction of 1.4527 at 20°,
a molecular weight of 422 and an iodine number below 10.
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c. Vitamin A. Synthetic vitamin A palmitate (Abbott Laboratories) was reduced by the
method of Karrer and Mon (8). Twenty five grams of the vitamin were dissolved in ethyl
acetate and shaken at room temperature under 60 psi of hydrogen. To this solution 0.1 gram
portions of platinum oxide were added every 4 hours. After 40 hours an estimated 30 to 4fi%
of the theoretical amount of hydrogen was absorbed. The reduced compound was recovered
from the solvent, since it could not be purified by distillation.
d. Stearic acid, the saturated derivative of oleic and linoleic acids, was obtained from
Merck and Co. and dissolved in absolute alcohol to a 25 to 50% final concentration for use
in animals.
All the hydrogenated compounds were tested for in vivo depilatory and in vitro sulfhy-
dryl inhibitory effects in the same way as was described above. Experiments were carried
out simultaneously with the unsaturated compound and its saturated derivative to mini-
mize the experimental errors.
3. Clinical studies with topically applied vitamin A
Synthetic vitamin A palmitate, obtained through the courtesy of lloffmann-LaRoche,
Inc. and Abbott Laboratories, was incorporated into various ointment bases. The following
ointment bases were used:
a. A 2:1 mixture of cold cream (Lilly) with cocoa butter.
b. Neobase (Burroughs-Wcllcome)
c. Dome Creme (Dome Chemicals, Inc.)
d. Dermovan (Texas Pharmacal Co.)
These ointments were prepared in two strengths: with lj!4 and 3% vitamin A* (50,000
and 100,000 units of vitamin A palmitate/Gm ointment). Two types of 3% vitamin A
shake lotions (with Lubriderm (Texas Pharmaeal Co.) and with glycerin, water and alco-
hol) were also prepared. All vitamin A preparations were used within two months after
the addition of vitamin A to the ointment bases.
Among the patients treated were 6 with ichthyosis, 2 with psoriasis and 1 with multiple
epidermal dysplasia. Other patients are currently under study. In every case one side was
treated with the ointment base alone, the other with the vitamin A ointment. General ap-
plication of vitamin A ointments was started only when, after several weeks, the site treated
with vitamin A showed markedly diminished scaling or keratinization over the control area.
When there was no improvement or equal improvement in the areas treated with vitamin A
and in the control sites, topical application of the vitamin was discontinued.
RESULTS
1. Studies with human sebum
Male, female and children's sebum caused reversible hair loss in all rabbits
tested, after a single application of 0.5 to 1 ml. to the skin of the head. The hair
began to fall out in 10 to 12 days after treatment. No significant difference was
observed in the sulfhydryl inactivating power of male and female sebum in vitro.
Children's sebum, however, had a significantly lower sulfhydryl inhibitory po-
tency than adult sebum. (Table II.) When the in vitro effect of the "T-shirt
lipids" and of the saturated hydrocarbon fraction from human hair fat was
tested, good correlation was found between the depilatory potency, sulfhydryl
inhibitory action and degree of unsaturation (Table III).
* The author is of the opinion that the use of units in this instance is meaningless and
misleading, because it implies that in these ointments the vitamin is used as a replacement
therapy.
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2. Studies with the hydrogenated derivatives of the depilatory agents
In spite of repeated applications, hydrogenated vitamin A (perhydro-vitamin
A), perhydrosqualene and stearic acid had no depilatory effect in any of the ani-
mals tested. Alopecia was observed after application to the skin of rabbits of the
partially hydrogenated sebum sample.
The average sulfhydryl inhibitory potencies of normal adult sebum (iodine
number 76) and partially hydrogenated adult sebum (iodine number 26) are
represented in Table IV. In all individual determinations, partly hydrogenated
sebum had a weaker inhibitory action than samples of control adult sebum of the
same concentrations.
TABLE II
SEBUM CONCEN-
TBATION
INEIBITION IN PER CENT
.
—SIT groups of mouse liver . .Succmic dehydrogenase activity of mouse liver
Male Female Child Male Female Child
1:30
1:60
1:120
1:240
45
38
31
19
60
50
36
23
24
18
14
8
85
56
24
8
88
46
17
12
50
15
9
0
TABLE III
IODINE NUMBER DEPILATION —SH INHIBITION
Total T-shirt lipids
Petroleum ether insoluble fraction
Phospholipids
Water-soluble fraction
"Ether" fatty acids
Unsaturated acids
Saturated hydrocarbons
Not given
Not given
10
0
50
201
0
+
—
—
Not tested*
Not tested*
Not tested*
—
+
—
—
+
+
—
* Not enough material available for in vivo studies.
Among the hydrogenated derivatives, perhydrosqualene had no sulfhydryl in-
hibitory potency in vitro and no depilatory activity in vivo (Fig. 1). Stearic acid,
having a higher melting point than any of the other compounds tested, precipi-
tated in the aqueous reaction mixtures, and therefore its in vitro effect could not
be evaluated.
3. Therapeutic trials with locally applied vitamin A preparations
Of the 6 cases of ichthyosis treated with vitamin A ointments, four showed
improvement on the areas treated with vitamin A, while the control areas re-
mained unchanged. The other 2 cases improved equally well from vitamin A as
from the control base. The patients with psoriasis showed no change whatever
from topically applied vitamin A. A definite decrease in cutaneous horn formation
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and hyperkeratosis was observed from topical application of a 3% vitamin A
ointment in the patient with multiple epidermal hyperplasia, while the base alone
had no effect.
At the time of the writing of this manuscript, our first case of ichthyosis had
been under treatment for 7 months with topically applied vitamin A. During this
time she had received a total of approximately 1 lb. of vitamin A (cca. 1400 mil-
TABLE IV
TYPE OF SEBUIR
AVERAGE INHIBITION IN PER CENT
Succinic dehydrogenase
—SH groups of mouse liver activity of mouse liver
Adult control
Partly hydrogenated
31* 42t
22* 35j-
zI
H
0z
ML. SQUA LENE/ 100 MG. LIVER
ML PERHYDROSQUALENE/(00 MG LIVER
Fin. 1. Inactivation of sulfhydryl groups and succinic dehydrogenase in mouse liver by
squalene. Hydrogenation of squalene abolishes its inhibitory action.
lion units), incorporated in ointments. The case is described here in some detail
because it presents certain interesting features.
The patient was a 6 year old girl with severe ichthyosis. Generalized scaling was evident
from the time of birth, when the skin was brown and parchment-like, cracking on movement.
At the time of her first visit to the clinic, she presented generalized scaling, dry stiff skin
with accentuation of the horny layer on the palms, soles and elbows and follicular hyper-
keratoses of a brown color. The scalp was covered with thick, adherent scales; the hair was
thin and somewhat sparse. There was moderate ectropion present. Accumulation of horny
masses in the outer ear canal was at times so extensive that the hearing was impaired. There
* Average of 5 determinations with concentrations ranging from 1:2 to 1:16.
t Average of 9 determinations with concentrations ranging from 1:2 to 1:120.
INIC DEHYDROGENASE
—A SULFHVDRYL
60
40
20
0.06 0.12 0.25 0.5 1.0
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were no abnormalities of nails or teeth. The skin eruption showed cycles of erythema and
scaling, running usually over periods of 3 months. A twin brother had normal skin.
Previous therapy consisted of local application of cold cream with 30% cocoa butter at
night, Lubriderm during the day. Phisoderm was used as a soap substitute and bran baths
were taken. The scalp was treated with Pragmatar and Breck shampoo. Internally vitamin
A was given (50,000 units daily over a year per os), vitamin B supplements with iron and
Lederle's animal protein factor. Improvement from internal measures was negligible.
A vitamin A tolerance curve, determined by Dr. Irving J. Wolman of the Children's
Hospital in Philadelphia, gave the following results after oral administration of a large dose
of vitamin A:
SAMI'LE S TIME IN HOURS VITAMIN A IN NG/100 CC. CAROTENE IN NG/100 CC.
1 0 38 78
2 l 70 75
3 3 321 76
4 4 201 71
5 63 258 72
The test was done after vitamin A had been withdrawn for 1 week. Absorption of vitamin
A from the intestine thus did not seem to be impaired.
The patient was started on a 1% (50,000 units/gm.) vitamin A ointment in Dome creme
base. One arm was rubbed twice daily with the vitamin A ointment, the other control side
with the base alone. Four weeks later the area treated with vitamin A showed less scaling
than the control site. At this time scales were taken from the control side and from the
side treated with vitamin A and their sulfhydryl content was determined with Bennett's rea-
gent. In the scales taken from the side treated with vitamin A there were no demonstrable
sulfhydryl compounds present, while the control scales contained 32 ig-SH/100 mg. scales.
Since the ointment base appeared to be irritating (signs of folliculitis), it was exchanged
with a cold cream-cocoa butter base; this ointment is still being used without any untoward
effects. The vitamin A content of the ointment was raised to 3% (100,000 U/gm.) and this
ointment was applied all over the body once daily. At the same time oral administration of
vitamin A was discontinued. Under this treatment there was a marked improvement in 4
weeks. At present the patient receives topical treatment only, consisting of 1 daily inunction
with 3% vitamin A ointment. The daily applied doses are estimated at approximately 2
gms. of vitamin A (6 million units). In spite of these tremendous amounts, a blood sample
taken after two months yielded the following values, as determined by Dr. Hans Popper:
Carotene: 48 Lg%; total vitamin A: 49.58 ug%; vitamin A ester: 29.15 ig%; vitamin A al-
cohol:20.43 g%. Although the ester values which in the fasting adult amount to about 20%
of the total vitamin A values of the blood, are definitely high, it is also obvious that the
patient had no signs of hypervitnminosis A. By that time she had received about 120 gms.
(400 million units) of vitamin A on her skin.
At present the patient's condition is very much improved. The heavy scales on the scalp
have disappeared; the ear is not obstructed anymore at any time; the skin, although still
dry and slightly scaling, is smoother and softer than at any time before. In spite of con-
tinued therapy, relapses occur, but are less severe and of shorter duration than previous
similar episodes. The cyclic scaling and erythematous periods remained as before, un-
modified by the treatment.
The base appeared to be of considerable importance in the therapeutic results. The van-
ishing cream (Dermovan) caused itching, erythema and increased scaling, while Neobase
and Lubriderm were well tolerated by all patients. In the evaluation of topical treatment,
it is impossible to overemphasize the importance of control treatment with the ointment
bases alone (9). Repeatedly we have seen patients with mild ichthyosis or with xerosis who
improved from the ointment bases to the same extent as from the vitamin A ointments.
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The optimum strength of the vitamin A preparations has not yet been established. In the
7 year old girl with ichthyosis, two attempts to reduce the 3% vitamin A content to 13%
were followed by flareups. However, we cannot assume a definite connection between these
reactions and the reduction of the concentrations of the vitamin A ointments.
DISCUSSION
The present work confirms and extends our previous findings, showing that
human sebum has a depilatory effect in laboratory animals and that this effect
is due to the unsaturated fractions. We have definitely established that the de-
pilatory action is caused by sebum itself and not by some extraneous admixture
(e.g. hair lotions), because the sebum samples extracted from T-shirts had the
same in vivo and in vitro effects as the more impure hair fat. We also present
further evidence that unsaturation of the sebum and of its fractions is essential
for both the depilation and sulfhydryl inhibition. Saturated fractions had no
effect on hair growth in vivo and sulfhydryl compounds in vitro.
The theory, that the depilatory effect of unsaturated compounds in general
is due to the presence of the unsaturated groupings in the molecules, must be
Considered as definitely proved. Complete saturation of four depilatory substances
(vitamin A, squalene, oleic and linoleic acids) abolished their depilatory action.
The question, whether or not the depilatory action of sebum in animals has
anything to do with the development of common male baldness, cannot be
answered at present.
More direct evidence could be adduced if it were shown that children's sebum
has a less pronounced depilatory action than adult sebum. In our experiments no
such difference could be observed. This finding is not surprising if we take into
account our observations with partly hydrogenated sebum. In spite of an almost
65% saturation of sebum (as shown by a decrease of the iodine number from 76
to 27), the depilatory action, an all-or-none effect, was not noticeably influenced.
On the other hand, a significant decrease in the sulfhydryl inhibitory power was
achieved by hydrogenation of the sebum. Similarly, children's sebum, although
having a smaller sulfhydryl-binding capacity than adult sebum, still caused loss
of hair in animals. Obviously a complete saturation is necessary as in dodeca-
hydrosqualene or hydrogenated vitamin A, before the depilatory action disap-
pears.
When applied topically, large amounts of vitamin A are therapeutically effec-
tive. This finding raises serious doubts as to the validity of current beliefs re-
garding the mode of action of vitamin A, when administered in large doses for
the treatment of diseases characterized by excessive or abnormal keratinization.
Vitamin A has been introduced in the treatment of such diseases, on the basis,
that follicular hyperkeratosis was one of the prominent features of vitamin A
deficiency (10) * Large doses of vitamin A have been useful in the treatment of
a number of diseases with anomalous keratinization, like Darier's disease, pityri-
* J is seldom realized that follicular hyperkeratosis, like any other cutaneous mani-
festation, is a non-specific symptom. In fact, it occurs earlier and more frequently in vitamin
C deficiency than in vitamin A deficiency (11).
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asis rubra pilaris and, rarely, ichthyosis, to mention only a few. In some of these
cases there were signs of generalized vitamin A deficiency in the form of night
blindness or of low plasma vitamin A levels; in others, vitamin A metabolism was
apparently normal. It frequently occured that, after the administration of exces-
sive doses of vitamin A, clinical improvement did not parallel the disappearance
of the night-blindness or the rise of the plasma vitamin A level (12).
In order to reconcile these contradictions, the theory has been advanced that
even in the absence of symptoms of a generalized vitamin A deficiency, there
may well exist a localized deficiency, restricted to the skin alone. To this hypo-
thetical condition the name "dysvitaminosis" was given. A "dysvitaminosis"
was defined as an isolated organ deficiency, caused by abnormal absorption and
utilization of, or demand for the vitamin by the skin (13, 14). During the 14
years of this concept's existence no experimental or clinical evidence has been
brought forth in support of it. We suggest that the term "dysvitaminosis" be
discontinued.
It appears to us that much of the confusion regarding the mode of action of
large doses of vitamin A is due to a basic misconception, namely the belief that
clinical improvement from massive doses of vitamin A is in itself proof that the
disease is a vitamin deficiency. This belief is unacceptable from a scientific stand-
point. The effect of large doses of a vitamin is different from the action of small,
physiologic doses. The mere fact that such large doses are required over long
periods of time and even then the condition is only temporarily alleviated, is in
itself proof that the disease is not due to a vitamin deficiency.
Our clinical and experimental data led us to an entirely different concept of the
mode of action of large doses of vitamin A in cutaneous metabolism. Similar
views have been partially indicated by some authors in the past (12, 15, 16, 17,
18). The essential elements of our conclusions may be summarized as follows:
1. The action of large doses of vitamin A is a drug effect and not a vitamin
effect, a pharmacodynamic and not a physiologic action. Hence, when a cutane-
ous disease is favorably influenced by massive doses of this vitamin, the thera-
peutic result in itself is insufficient evidence to classify the disease as a vitamin
deficiency. *
2. The effect of vitamin A is a direct, local effect on the epidermis and appar-
ently consists of some suppressive action on keratin formation. Hence, topical
application of vitamin A preparations is often successful when systemic admin-
istration fails. At present, there is no foundation for the belief that the effect of
vitamin A upon the skin is indirect and mediated by the liver or the endocrine
system.
* This statement holds true not only for vitamin A, but for other vitamins as well. If
the concept of dysvitaminosis were extended to all of its logical implications, Addison's
disease would have to be called a dysvitaminosis C, because the hyperpigmentation in this
disease may be bleached with massive doses of vitamin C; or lupus vulgaris would have to
be classified as a vitamin D deficiency, a regrettable assumption, made by some dermatolo-
gists. For an extreme example of this thinking, the reader is referred to the "cure" of pruri-
tus with massive doses of nicotinic acid amide; hence pruritus has become a "dyscotinosis"
(19).
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3. This direct, local pharmacologic effect of large doses of vitamin A is probably
not specific and it is likely that it may be obtained with other related compounds.
Experiments of this nature are in progress.
The above views are well exemplified by our case of ichthyosis. In this girl the
blood vitamin A levels and the absorption of vitamin A from the intestine were
normal. Large doses of vitamin A by mouth over many months had no effect on
the scaling. Excessive doses, applied to the skin, effected an improvement which
was restricted to the site of application. This improvement was objectively
manifested by an apparently more complete or normal process of keratinization
with a decrease in the sulfhydryl content of the horny scales. The vitamin A level
of the blood did not rise in the course of the treatment. In spite of the marked
improvement, occasional relapses occurred, as during the normal course of the
disease.
The finding that local application of excessive doses of vitamin A does not
increase the blood vitamin A level is surprising. Similar observations were made
by Dr. S. H. Rubin in the laboratories of Hoffmann-LaRoche, Inc. In his experi-
ments a single application of 101,000 and 204,000 units of vitamin A palmitate
(in a Carbowax base or in a water-glycerin lotion) to the skin of the forearms in
5 normal subjects, caused no significant increase in plasma vitamin A levels after
5 or 24 hours. Over 48 hours, repeated applications of vitamin A palmitate
(total dose of 4,600,000 units) to the chest and back of 2 subjects did not increase
the plasma vitamin A level. Having in mind the many unwarranted speculations
concerning vitamin A, we refrain from suggesting any explanation for the above
described phenomenon, but emphasize the necessity for further scientific in-
vestigation in this field.
SUMMARY
1. The inhibitory action upon keratin formation of human sebum and of vita-
min A was investigated. This anti-keratinizing activity was manifested in inhibi-
tion of hair growth in animals and reduction of scaling in man.
2. Human sebum (both male and female), obtained either by extraction of hair
or from T-shirts, caused reversible depilation in rabbits, 10—12 days after a single
application to the skin. The depilatory activity was due to the unsaturated
fractions of sebum which inactivated free sulfhydryl groups in vitro. Saturated
fractions had no effect on hair growth or on sulfhydryl groups.
3. Partly hydrogenated adult sebum (iodine number 27) had a significantly
lower sulfhydryl-inhibitory potency than the corresponding sample of control
sebum (iodine number 76). Children's sebum inactivated sulfhydryl compounds
to a significantly lesser extent than adult sebum. Both the partly hydrogenated
and children's sebum retrained, however, their depilatory potencies.
4. Definite evidence was advanced that the unsaturated groups are essential
for the depilatory activity. Complete hydrogenation of squalene abolished the
depilatory effect together with the sullhydryl-inhibitory potency. Similarly,
vitamin A, oleic, and linoleic acids lost their depilatory activities after hydrog-
enation.
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5. Four out of 6 cases of ichthyosis and one with multiple epidermal dysplasia
were markedly improved from topical application of 1% (50,000 U/gm.) and
3% (100,000 U/gm.) vitamin A ointments. The improvement was limited to the
site of the application of the vitamin A ointments. Control areas, treated with
the ointment bases alone, did not show any change. Improvement in ichthyosis
was manifested by marked reduction of the scaling with decrease of the sulfhydryl
content of the scales. No beneficial effect was observed from topical application
of vitamin A ointments in 2 cases of psoriasis.
6. Local application of excessive doses of vitamin A did not cause any signifi-
cant increase in total vitamin A plasma levels.
7. The theory is advanced that the effect of massive doses of vitamin A is a
direct, local and probably non-specific drug effect upon the epidermis. It is not
permissible to assume that a disease is a vitamin deficiency, solely on the basis
that it is benefited by large doses of a vitamin. It is suggested that the concept of
"dysvitaminosis" (alleged cutaneous vitamin A deficiency) be abandoned.
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DISCUSSION
DR. CARL T. NELSON,New York, N. Y.: It is my understanding that vitamin
A does not inactivate the sulfhydryl compounds in vitro. If this is so, what is the
explanation for the inhibition of keratinization in ichthyosis after the local
application of vitamin A and why do the scales from the treated areas have a
lower sulfhydryl content?
DR. PETER FLxscn, Philadelphia: In answer to Dr. Nelson's question, we
believe that not vitamin A itself, but one of its degradation products, is the active
agent which inhibits keratin formation and inactivates free sulfhydryl groups in
the ichthyotic scales. The in vivo inhibition of sulfhydryl in ichthyotic scales by
vitamin A is not comparable to the in vitro action: in vitro experiments are carried
out within a few hours, while the in vivo effect was measured after vitamin A had
been applied locally for several weeks.
I may mention here that we produced baldness in rabbits by internal admin-
istration of oleic acid. This finding is of interest in connection with the so-called
X-disease of cattle. This serious condition is characterized by hair loss, keratiniz-
ing metaplasia of the mucous membranes and degeneration of the internal organs.
The free fatty acid fraction of the feed has been held responsible for this condition.
In this disease the plasma vitamin A level is decreased, although it is not a pri-
mary vitamin A deficiency. (Hansel, McEntee and Olafson: Cornell Vet., 41: 237,
367, 1951.)
